- Home
- CAG vs ICLR Comparison
CAG vs ICLR Comparison
Compare CAG & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAG | ICLR |
|---|---|---|
| Founded | 1919 | 1990 |
| Country | United States | Ireland |
| Employees | 26100 | N/A |
| Industry | Packaged Foods | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 7.1B |
| IPO Year | 1994 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CAG | ICLR |
|---|---|---|
| Price | $15.75 | $104.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $18.86 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 13.6M | 903.6K |
| Earning Date | 04-01-2026 | 04-29-2026 |
| Dividend Yield | ★ 8.90% | N/A |
| EPS Growth | ★ 233.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,500,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.04 | $66.57 |
| 52 Week High | $27.68 | $211.00 |
Technical Indicators
Market Signals| Indicator | CAG | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 45.78 |
| Support Level | N/A | $95.75 |
| Resistance Level | $19.54 | $113.88 |
| Average True Range (ATR) | 0.52 | 4.26 |
| MACD | -0.05 | 2.33 |
| Stochastic Oscillator | 32.39 | 82.23 |
Price Performance
Historical ComparisonAbout CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.